{"pmid":32348003,"title":"The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.","text":["The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.","Worldwide Coronavirus Disease 2019 (COVID-19) epidemic makes the management of acute myocardial infarction (AMI) more complicated, effective treatment without further dissemination is thus quite challenging. Recently, we successfully treated three representative AMI cases, by sharing these detailed procedures, we summarized some important issues including patient screening, reperfusion strategy selecting, personnel/catheter lab protection principle, as well as operation tactics, which may lend precious experience on AMI treating during the ongoing COVID-19 pandemic situation.","Catheter Cardiovasc Interv","Xiao, Zhichao","Xu, Chang","Wang, Daowen","Zeng, Hesong","32348003"],"abstract":["Worldwide Coronavirus Disease 2019 (COVID-19) epidemic makes the management of acute myocardial infarction (AMI) more complicated, effective treatment without further dissemination is thus quite challenging. Recently, we successfully treated three representative AMI cases, by sharing these detailed procedures, we summarized some important issues including patient screening, reperfusion strategy selecting, personnel/catheter lab protection principle, as well as operation tactics, which may lend precious experience on AMI treating during the ongoing COVID-19 pandemic situation."],"journal":"Catheter Cardiovasc Interv","authors":["Xiao, Zhichao","Xu, Chang","Wang, Daowen","Zeng, Hesong"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348003","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ccd.28951","keywords":["covid-19","acute myocardial infarction","pandemic","percutaneous coronary intervention","personnel protection equipment"],"topics":["Prevention"],"weight":1,"_version_":1665441658306560000,"score":8.599203,"similar":[{"pmid":32311816,"title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32311816"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311816","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28946","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664632501467873280,"score":508.42517},{"pmid":32330544,"pmcid":"PMC7173829","title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.","J Am Coll Cardiol","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32330544"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option."],"journal":"J Am Coll Cardiol","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330544","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jacc.2020.04.039","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1665420537552175105,"score":506.5971},{"pmid":32320138,"title":"Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian\"247\" National Committee's position paper on primary percutaneous coronary intervention.","text":["Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian\"247\" National Committee's position paper on primary percutaneous coronary intervention.","World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it.","Catheter Cardiovasc Interv","Sadeghipour, Parham","Talasaz, Azita H","Eslami, Vahid","Gerayeli, Babak","Vojdanparast, Mohammad","Sedaghat, Mojtaba","Moosavi, Abouzar Fakhr","Alipour-Parsa, Saeed","Aminian, Bahram","Firouzi, Ata","Ghafari, Samad","Ghasemi, Massoud","Saleh, Davood Kazemi","Khosravi, Alireza","Kojuri, Javad","Noohi, Feridoun","Pourhosseini, Hamid","Salarifar, Mojtaba","Salehi, Mohamad Reza","Sezavar, Hashem","Shabestari, Mahmoud","Soleimani, Abbas","Tabarsi, Payam","Parsa, Amir Farhang Zand","Abdi, Seifollah","32320138"],"abstract":["World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it."],"journal":"Catheter Cardiovasc Interv","authors":["Sadeghipour, Parham","Talasaz, Azita H","Eslami, Vahid","Gerayeli, Babak","Vojdanparast, Mohammad","Sedaghat, Mojtaba","Moosavi, Abouzar Fakhr","Alipour-Parsa, Saeed","Aminian, Bahram","Firouzi, Ata","Ghafari, Samad","Ghasemi, Massoud","Saleh, Davood Kazemi","Khosravi, Alireza","Kojuri, Javad","Noohi, Feridoun","Pourhosseini, Hamid","Salarifar, Mojtaba","Salehi, Mohamad Reza","Sezavar, Hashem","Shabestari, Mahmoud","Soleimani, Abbas","Tabarsi, Payam","Parsa, Amir Farhang Zand","Abdi, Seifollah"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320138","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28889","keywords":["acute myocardial infarction/stemi","percutaneous coronary intervention","thrombolytic therapy"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Iranian"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"_version_":1664815087737634816,"score":193.04556},{"pmid":32337148,"pmcid":"PMC7179991","title":"Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","text":["Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment.","Cureus","Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath","32337148"],"abstract":["Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment."],"journal":"Cureus","authors":["Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337148","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7759/cureus.7782","keywords":["acute respiratory distress syndrome","atypical covid","covid-19","stemi"],"topics":["Case Report"],"weight":1,"_version_":1665264685620920321,"score":192.84654},{"pmid":32339038,"title":"STEMI Care and COVID-19: The Value Proposition of Pharmacoinvasive Therapy.","text":["STEMI Care and COVID-19: The Value Proposition of Pharmacoinvasive Therapy.","The coronavirus 2019 (COVID-19) pandemic has dramatically altered the delivery of reperfusion therapy for patients with ST-elevation myocardial infarction (STEMI). At this crucial time, it seems prudent to re-evaluate STEMI reperfusion pathways.","Circ Cardiovasc Qual Outcomes","Bainey, Kevin R","Bates, Eric R","Armstrong, Paul W","32339038"],"abstract":["The coronavirus 2019 (COVID-19) pandemic has dramatically altered the delivery of reperfusion therapy for patients with ST-elevation myocardial infarction (STEMI). At this crucial time, it seems prudent to re-evaluate STEMI reperfusion pathways."],"journal":"Circ Cardiovasc Qual Outcomes","authors":["Bainey, Kevin R","Bates, Eric R","Armstrong, Paul W"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339038","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1161/CIRCOUTCOMES.120.006834","keywords":["pharmacoinvasive therapy"],"topics":["Prevention"],"weight":1,"_version_":1665264685519208448,"score":179.05115}]}